The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death-Reference-Cited by-同舟云学术

The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death

Published:2009-11-01 Issue:21 Volume:115 Page:5071-5083
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Chen L. Leon,Nolan Matthew E.,Silverstein Melvin J.,Mihm Martin C.,Sober Arthur J.,Tanabe Kenneth K.,Smith Barbara L.,Younger Jerry,Michaelson James S.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24565/fullpdf

Reference17 articles.

1. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases;Carter;Cancer.,1989

2. Predicting the survival of patients with breast carcinoma using tumor size;Michaelson;Cancer.,2002

3. The effect of tumor size and lymph node status on breast carcinoma lethality;Michaelson;Cancer.,2003

4. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up;Elston;Histopathology.,1991

5. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas;Diab;J Clin Oncol.,1999

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using Nomograms Wisely: Predicting Sentinel Node Positivity in Melanoma;Annals of Surgical Oncology;2024-08-13

2. External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer;European Journal of Cancer;2023-12

3. On the treatment of melanoma: A mathematical model of oncolytic virotherapy;Mathematical Biosciences;2023-11

4. Population-based prognostic instrument (SweMR 2.0) for melanoma-specific survival - An ideal tool for individualised treatment decisions for Swedish patients;European Journal of Surgical Oncology;2023-10

5. Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer;Cancers;2023-09-07